Morgan Stanley Procaps Group, S.A. Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Procaps Group, S.A. stock. As of the latest transaction made, Morgan Stanley holds 100 shares of PROC stock, worth $250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$250
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PROC
# of Institutions
11Shares Held
104KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA28.9KShares$72,6340.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny25.3KShares$63,5020.0% of portfolio
-
United Maritime Capital LLC New York, NY14KShares$35,1400.64% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il12.5KShares$31,3740.0% of portfolio
-
State Street Corp Boston, MA12.4KShares$31,0310.0% of portfolio
About Procaps Group, S.A.
- Ticker PROC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 112,824,000
- Market Cap $283M
- Description
- Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and ...